| Structure | Chemical Name | CAS | MF |
|
2H-Pyrrole-4-carboxylicacid,3,4-dihydro-4-methyl-,ethylester(9CI)
|
148028-68-6
|
C8H13NO2
|
|
Cyclohexanecarboxylic acid, 2-acetyl- (9CI)
|
148029-00-9
|
C9H14O3
|
|
(Des-Gly10,D-Ala6,Pro-NHEt9)-LHRH
|
148029-26-9
|
C56H78N16O12
|
|
Eptifibatide Acetate
|
148031-34-9
|
C35H49N11O9S2
|
|
Pyridine, 4-(2-ethoxyphenyl)-1,2,3,6-tetrahydro-1-methyl- (9CI)
|
148033-46-9
|
C14H19NO
|
|
6-BROMO-1H-IMIDAZO[4,5-B]PYRIDIN-2(3H)-ONE
|
148038-83-9
|
C6H4BrN3O
|
|
1H-Imidazo[4,5-b]pyridin-2-amine,N-methyl-(9CI)
|
148038-85-1
|
C7H8N4
|
|
5H-Imidazo[4,5-b]pyridin-5-one,1,3a,4,7a-tetrahydro-(9CI)
|
148040-12-4
|
C6H7N3O
|
|
5,5,6,6,6-PENTAFLUOROHEXANE ACID
|
148043-70-3
|
C6H7F5O2
|
|
4,4,5,5,5-Pentafluoro-1-pentanol
|
148043-73-6
|
C5H7F5O
|
|
L-Norvaline, 4,4-difluoro- (9CI)
|
148043-97-4
|
C5H9F2NO2
|
|
1,3,5-Tri(9-carbazolyl)benzene
|
148044-07-9
|
C42H27N3
|
|
4-fluoro-2-hydroxyestradiol
|
148044-30-8
|
C18H23FO3
|
|
2-fluoro-4-hydroxyestradiol
|
148044-31-9
|
C18H23FO3
|
|
1-(3-(1-Hydroxy-3-methylbutyl)-4-methoxyphenyl)ethan-1-one
|
148044-44-4
|
C14H20O3
|
|
25-Hydroxycycloart-23-en-3-one
|
148044-47-7
|
C30H48O2
|
|
hemoglobin Ozieri
|
148046-83-7
|
|
|
1H-Inden-1-one,2,3-dihydro-6,7-dihydroxy-4-nitro-(9CI)
|
148050-55-9
|
C9H7NO5
|
|
1H-Indene-4-carboxylicacid,2,3-dihydro-6,7-dihydroxy-1-oxo-(9CI)
|
148050-69-5
|
C10H8O5
|
|
1H-Indene-4-carboxylic acid, 2,3-dihydro-6,7-dimethoxy-1-oxo-
|
148050-74-2
|
C12H12O5
|
|
1H-Inden-1-one, 2-acetyl-2,3-dihydro-6,7-dihydroxy- (9CI)
|
148050-82-2
|
C11H10O4
|
|
5-AMINO-N,N''-BIS[2-ACETOXY-1-(ACETOXYMETHYL)ETHYL]-2,4,6-TRIIODOISOPHTHALAMIDE
|
148051-08-5
|
C22H26I3N3O10
|
|
H-LEU-SER-SER-PHE-VAL-ARG-ILE-NH2
|
148054-14-2
|
C38H65N11O9
|
|
Bicyclo[2.2.1]hepta-2,5-diene-2-carbonyl chloride, 3-acetyl- (9CI)
|
148054-41-5
|
C10H9ClO2
|
|
Bicyclo[2.2.1]hepta-2,5-diene-2-carbonyl chloride, 3-methoxy- (9CI)
|
148054-42-6
|
C9H9ClO2
|
|
Bicyclo[2.2.1]hepta-2,5-diene-2-carbonyl chloride, 3-nitro- (9CI)
|
148054-43-7
|
C8H6ClNO3
|
|
(S)-ALPHA-PHENYL-1-PIPERIDINEETHANAMINE
|
148054-65-3
|
C13H20N2
|
|
1,2-bis(9,16-dioxahexacosa-11,13-diynoyl)-sn-3-phosphocholine
|
148057-01-6
|
C56H96NO12P
|
|
1-Trityl-1H-[1,2,4]triazole-3-carbaldehyde
|
148062-66-2
|
C22H17N3O
|
|
1,4-Benzenedicarboxaldehyde, 2,3-dihydroxy-
|
148063-59-6
|
C8H6O4
|
|
3-PYRIDINECARBOXYLIC ACID, 2,5-DICHLORO-, ETHYL ESTER
|
148065-10-5
|
C8H7Cl2NO2
|
|
1,3-Dioxolane-4-carboxamide,2,2-dimethyl-,(R)-(9CI)
|
148065-34-3
|
C6H11NO3
|
|
(S)-1-(ANTHRACEN-10-YL)ETHANAMINE
|
148065-53-6
|
C16H15N
|
|
ITSFEEAKGLDRINERMPPRRDAMP
|
148067-21-4
|
C124H205N39O39S2
|
|
N,9-O-DIACETYLNEURAMINIC ACID AMMONIUM
|
148067-22-5
|
C13H24N2O10
|
|
|
17-kDa immunogen, Treponema pallidum
|
148068-13-7
|
|
|
|
CsaA protein
|
148068-30-8
|
|
|
STYRENE OXIDE-D8, 97+ ATOM % D
|
148076-33-9
|
C8D8O
|
|
N-(5-thioxo-L-prolyl)-L-cysteine
|
148076-52-2
|
C8H12N2O3S2
|
|
Appenolide A
|
148077-10-5
|
C14H20O3
|
|
Appenolide B
|
148077-11-6
|
C14H22O3
|
|
Appenolide C
|
148077-12-7
|
C14H22O3
|
|
lincophenicol
|
148077-13-8
|
C18H27N3O5
|
|
chloramlincomycin
|
148077-14-9
|
C11H19Cl2NO6S
|
|
sparsolincomycin
|
148077-15-0
|
C17H25N3O8S
|
|
sparsopuromycin
|
148077-16-1
|
C20H24N8O6
|
|
1-diphosphoinositol pentakisphosphate
|
148077-18-3
|
C6H19O27P7
|
|
bis(1,4)-diphosphoinositol tetrakisphosphate
|
148077-19-4
|
C6H20O30P8
|
|
(4-(dip-tolylaMino)phenyl)Methanol
|
148077-49-0
|
C21H21NO
|
|
4-(4-Methylpiperazin-1-ylmethyl)benzoyl chloride
|
148077-69-4
|
C13H17ClN2O
|
|
1,2-bis(15-oxapentacosa-10,12-diynoyl)-sn-phosphocholine
|
148077-85-4
|
C56H96NO10P
|
|
1-O-Hexyl-2,3,5-trimethylhydroquinone
|
148081-72-5
|
C15H24O2
|
|
FMOC-LYS(DNP)-OH
|
148083-64-1
|
C27H26N4O8
|
|
exfoliamycin
|
148084-37-1
|
C22H26O9
|
|
anthrotainin
|
148084-40-6
|
C20H17NO9
|
|
C60 DERIVATIVES
|
148085-32-9
|
C68H8
|
|
XML 2
|
148091-75-2
|
C34H38N4O10S2
|
|
|
Pigment green 13
|
148092-61-9
|
|
|
|
INO2 protein
|
148093-80-5
|
|
|
|
suv3 gene product
|
148093-84-9
|
|
|
3-CHLORO-PIPERIDINE HYDROCHLORIDE
|
148096-22-4
|
C5H11Cl2N
|
|
2-phenyl-2-(piperidin-4-ylidene)acetonitrile hydrochloride
|
148096-23-5
|
C13H15ClN2
|
|
DWC 751
|
148098-42-4
|
C21H20N8O5S2.H2O4S
|
|
AC-LYS(FMOC)-OH
|
148101-51-3
|
C23H26N2O5
|
|
1H-Pyrrole,2-(ethoxymethyl)-(9CI)
|
148103-76-8
|
C7H11NO
|
|
Dimethyl 1,4-benzenedicarboxylate polymer with 1,4-cyclohexanedimethanol, 1,2-ethandiol and 2,2'-oxybis[ethanol]
|
148105-13-9
|
C24H42O11
|
|
3-Piperidinecarboxylicacid,6-(acetylamino)-5-hydroxy-,[3R-(3alpha,5alpha,6beta)]-(9CI)
|
148112-84-9
|
C8H14N2O4
|
|
Carbamic acid, (2-amino-1-formylethenyl)-, 1,1-dimethylethyl ester, (E)- (9CI)
|
148113-69-3
|
C8H14N2O3
|
|
Carbamic acid, (2-amino-1-formylethenyl)-, 1,1-dimethylethyl ester, (Z)- (9CI)
|
148113-70-6
|
C8H14N2O3
|
|
1,3-Dioxane, 2-ethynyl-2-methyl- (9CI)
|
148118-61-0
|
C7H10O2
|
|
5-(2,4-dichlorobenzylidene)pyrimidine-2,4,6(1H,3H,5H)-trione
|
148119-30-6
|
C11H6Cl2N2O3
|
|
2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-[3-(2-methoxyphenyl)-2-propenylidene]-
|
148119-36-2
|
C14H12N2O4
|
|
1-BENZYL-4-(4-NITROBENZYL)PIPERAZINE
|
148120-37-0
|
C18H21N3O2
|
|
Benzenamine, 2-ethyl-6-(1-iminoethyl)-
|
148121-17-9
|
C10H14N2
|
|
1,2,5-Oxadiazole-3-carboxylic acid, methyl ester (9CI)
|
148122-20-7
|
C4H4N2O3
|
|
1H-Purine-2,6-dione, 7-benzoyl-8-(dimethylamino)-3,7-dihydro-1,3-dimethyl-
|
148122-87-6
|
C16H17N5O3
|
|
1H-Purine-2,6-dione, 8-(dimethylamino)-3,7-dihydro-1,3-dimethyl-7-(4-nitrobenzoyl)-
|
148122-88-7
|
C16H16N6O5
|
|
1H-Purine-2,6-dione, 8-(dimethylamino)-7-[4-(dimethylamino)benzoyl]-3,7-dihydro-1,3-dimethyl-
|
148122-89-8
|
C18H22N6O3
|
|
1H-Purine-2,6-dione, 7-benzoyl-8-bromo-3,7-dihydro-1,3-dimethyl-
|
148122-90-1
|
C14H11BrN4O3
|
|
Cyclopropanecarboxylic acid, 2-nitro-, 1,1-dimethylethyl ester, (1R,2R)-rel-
|
148124-02-1
|
C8H13NO4
|
|
LAUROYL ETHYLENEDIAMINE TRIACETIC ACID
|
148124-42-9
|
C20H36N2O7
|
|
Atorvastatin LactaM Phenanthrene CalciuM Salt IMpurity
|
148127-12-2
|
C33H32FN2O6-
|
|
4-METHYLENEPIPERIDINE
|
148133-82-8
|
C6H11N
|
|
3-Thiophenecarboxaldehyde,oxime,(E)-(9CI)
|
148134-23-0
|
C5H5NOS
|
|
4-[2-(2-FLUORO-PHENYL)-ETHYL]-PIPERIDINEHYDROCHLORIDE
|
148135-85-7
|
C13H19ClFN
|
|
4-[2-(4-Fluorophenyl)ethyl]-piperidine HCl
|
148135-87-9
|
C13H19ClFN
|
|
4-[2-(4-CHLORO-PHENYL)-ETHYL]-PIPERIDINE
|
148135-88-0
|
C13H18ClN
|
|
4-[2-(4-Methoxyphenyl)ethyl]piperidine HCl
|
148135-92-6
|
C14H22ClNO
|
|
4-[2-(4-CHLOROPHENYL)ETHYL]PIPERIDINE HYDROCHLORIDE
|
148136-03-2
|
C13H19Cl2N
|
|
2-HYDROXY-7-FLUOROQUINOLINE
|
148136-14-5
|
C9H6FNO
|
|
cyclo(glycyl-prolyl-psi(CH2NH)-glycyl-phenylalanyl-prolyl)
|
148138-57-2
|
C23H31N5O4
|
|
9-(3'-aza-4'-hexyl-1',2',3',4'-tetradeoxyhexopyranos-1'-yl)-8-bromoadenine
|
148143-68-4
|
C16H25BrN6O2
|
|
Atorvastatin Related Compound D (20 mg) (Epoxide impurity, or 3-(4-Fluorobenzoyl)-2-isobutyryl-3-phenyl-oxirane-2- carboxylic acid phenylamide)
|
148146-51-4
|
C26H22FNO4
|
|
BENZYL 4-(N-METHOXY-N-METHYLCARBAMOYL)PIPERIDINE-1-CARBOXYLATE
|
148148-48-5
|
C16H22N2O4
|
|
Pyridine, 3-(4-piperidinylMethyl)-
|
148148-60-1
|
C11H16N2
|
|
3-Cyclohexene-1-propanal,4-ethoxy-6-methyl-2-oxo-,trans-(9CI)
|
148149-04-6
|
C12H18O3
|
|
4-Pyrimidinecarboxylicacid,6-methyl-,ethylester(9CI)
|
148149-29-5
|
C8H10N2O2
|
|
14-deoxycrassin
|
148149-82-0
|
C20H30O3
|
|
pseudoplexaurol
|
148149-83-1
|
C20H32O2
|
|
1-[N-FLUORENYLMETHOXYCARBONYL-(1S)-1-AMINO-2-HYDROXYETHYL]-4-METHYL-2,6,7-TRIOXABICYCLO[2.2.2]OCTANE
|
148150-68-9
|
C23H25NO6
|